Company Filing History:
Years Active: 2018-2025
Title: Innovations of Inventor Wenwei Lin
Introduction
Wenwei Lin is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of biomedical research, particularly in the study of GTPase-Activating Protein SH3 Domain-Binding Proteins (G3BP). With a total of five patents to his name, Lin's work has the potential to impact various therapeutic areas.
Latest Patents
Among his latest patents is a method for identifying modulators of G3BP activity. This innovative method provides a way to identify lead or candidate compounds that can modulate the activity of G3BP. The process involves determining whether a compound affects the interaction between the N-terminal Nuclear Transport Factor 2-like (NTF2L) domain of G3BP and the FGDF peptide of ubiquitin specific protease 10 (USP10) or non-structural protein 3 (nsP3). This patent highlights Lin's focus on understanding the molecular mechanisms that could lead to new therapeutic strategies.
Career Highlights
Wenwei Lin is currently affiliated with St. Jude Children's Research Hospital, where he continues to advance his research. His work at this prestigious institution allows him to collaborate with leading scientists and contribute to groundbreaking discoveries in pediatric medicine.
Collaborations
Lin has worked alongside esteemed colleagues such as Taosheng Chen and J Paul Taylor. These collaborations have further enriched his research and expanded the impact of his innovations.
Conclusion
Wenwei Lin's contributions to the field of biomedical research through his patents and collaborations demonstrate his commitment to advancing scientific knowledge. His innovative methods for identifying modulators of G3BP activity hold promise for future therapeutic developments.